216 related articles for article (PubMed ID: 25845427)
21. Sonic hedgehog (Shh) signaling promotes tumorigenicity and stemness via activation of epithelial-to-mesenchymal transition (EMT) in bladder cancer.
Islam SS; Mokhtari RB; Noman AS; Uddin M; Rahman MZ; Azadi MA; Zlotta A; van der Kwast T; Yeger H; Farhat WA
Mol Carcinog; 2016 May; 55(5):537-51. PubMed ID: 25728352
[TBL] [Abstract][Full Text] [Related]
22. Honokiol inhibits U87MG human glioblastoma cell invasion through endothelial cells by regulating membrane permeability and the epithelial-mesenchymal transition.
Joo YN; Eun SY; Park SW; Lee JH; Chang KC; Kim HJ
Int J Oncol; 2014 Jan; 44(1):187-94. PubMed ID: 24247297
[TBL] [Abstract][Full Text] [Related]
23. Glioblastoma-derived cells
Witusik-Perkowska M; Zakrzewska M; Sikorska B; Papierz W; Jaskolski DJ; Szemraj J; Liberski PP
Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28522553
[TBL] [Abstract][Full Text] [Related]
24. Differential gene expression in peritumoral brain zone of glioblastoma: role of SERPINA3 in promoting invasion, stemness and radioresistance of glioma cells and association with poor patient prognosis and recurrence.
Nimbalkar VP; Kruthika BS; Sravya P; Rao S; Sugur HS; Verma BK; Chickabasaviah YT; Arivazhagan A; Kondaiah P; Santosh V
J Neurooncol; 2021 Mar; 152(1):55-65. PubMed ID: 33389566
[TBL] [Abstract][Full Text] [Related]
25. Upregulation of miR-181s reverses mesenchymal transition by targeting KPNA4 in glioblastoma.
Wang H; Tao T; Yan W; Feng Y; Wang Y; Cai J; You Y; Jiang T; Jiang C
Sci Rep; 2015 Aug; 5():13072. PubMed ID: 26283154
[TBL] [Abstract][Full Text] [Related]
26. EMT-like process in glioblastomas and reactive astrocytes.
Iser IC; Lenz G; Wink MR
Neurochem Int; 2019 Jan; 122():139-143. PubMed ID: 30496766
[TBL] [Abstract][Full Text] [Related]
27. Helicobacter pylori-induced epithelial-mesenchymal transition, a potential role of gastric cancer initiation and an emergence of stem cells.
Choi YJ; Kim N; Chang H; Lee HS; Park SM; Park JH; Shin CM; Kim JM; Kim JS; Lee DH; Jung HC
Carcinogenesis; 2015 May; 36(5):553-63. PubMed ID: 25784376
[TBL] [Abstract][Full Text] [Related]
28. Osthole inhibits insulin-like growth factor-1-induced epithelial to mesenchymal transition via the inhibition of PI3K/Akt signaling pathway in human brain cancer cells.
Lin YC; Lin JC; Hung CM; Chen Y; Liu LC; Chang TC; Kao JY; Ho CT; Way TD
J Agric Food Chem; 2014 Jun; 62(22):5061-71. PubMed ID: 24828835
[TBL] [Abstract][Full Text] [Related]
29. Epithelial to mesenchymal transition markers are associated with an increased metastatic risk in primary cutaneous squamous cell carcinomas but are attenuated in lymph node metastases.
Toll A; Masferrer E; Hernández-Ruiz ME; Ferrandiz-Pulido C; Yébenes M; Jaka A; Tuneu A; Jucglà A; Gimeno J; Baró T; Casado B; Gandarillas A; Costa I; Mojal S; Peña R; de Herreros AG; García-Patos V; Pujol RM; Hernández-Muñoz I
J Dermatol Sci; 2013 Nov; 72(2):93-102. PubMed ID: 23928229
[TBL] [Abstract][Full Text] [Related]
30. Promising Prognosis Marker Candidates on the Status of Epithelial-Mesenchymal Transition and Glioma Stem Cells in Glioblastoma.
Takashima Y; Kawaguchi A; Yamanaka R
Cells; 2019 Oct; 8(11):. PubMed ID: 31653034
[TBL] [Abstract][Full Text] [Related]
31. Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance.
Kim YJ; Choi WI; Jeon BN; Choi KC; Kim K; Kim TJ; Ham J; Jang HJ; Kang KS; Ko H
Toxicology; 2014 Aug; 322():23-33. PubMed ID: 24793912
[TBL] [Abstract][Full Text] [Related]
32. The Fibronectin Expression Determines the Distinct Progressions of Malignant Gliomas via Transforming Growth Factor-Beta Pathway.
Chen CW; Yang CH; Lin YH; Hou YC; Cheng TJ; Chang ST; Huang YH; Chung ST; Chio CC; Shan YS; Cheng HC; Chang WT
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33917452
[TBL] [Abstract][Full Text] [Related]
33. Epithelial-to-mesenchymal(-like) transition as a relevant molecular event in malignant gliomas.
Kahlert UD; Nikkhah G; Maciaczyk J
Cancer Lett; 2013 May; 331(2):131-8. PubMed ID: 23268331
[TBL] [Abstract][Full Text] [Related]
34. TGF-β activates pericytes via induction of the epithelial-to-mesenchymal transition protein SLUG in glioblastoma.
Wirsik NM; Ehlers J; Mäder L; Ilina EI; Blank AE; Grote A; Feuerhake F; Baumgarten P; Devraj K; Harter PN; Mittelbronn M; Naumann U
Neuropathol Appl Neurobiol; 2021 Oct; 47(6):768-780. PubMed ID: 33780024
[TBL] [Abstract][Full Text] [Related]
35. In human glioblastomas transcript elongation by alternative polyadenylation and miRNA targeting is a potent mechanism of MGMT silencing.
Kreth S; Limbeck E; Hinske LC; Schütz SV; Thon N; Hoefig K; Egensperger R; Kreth FW
Acta Neuropathol; 2013 May; 125(5):671-81. PubMed ID: 23340988
[TBL] [Abstract][Full Text] [Related]
36. KITENIN promotes glioma invasiveness and progression, associated with the induction of EMT and stemness markers.
Lee KH; Ahn EJ; Oh SJ; Kim O; Joo YE; Bae JA; Yoon S; Ryu HH; Jung S; Kim KK; Lee JH; Moon KS
Oncotarget; 2015 Feb; 6(5):3240-53. PubMed ID: 25605251
[TBL] [Abstract][Full Text] [Related]
37. Transforming growth factor-β1 induces epithelial-mesenchymal transition and integrin α3β1-mediated cell migration of HSC-4 human squamous cell carcinoma cells through Slug.
Saito D; Kyakumoto S; Chosa N; Ibi M; Takahashi N; Okubo N; Sawada S; Ishisaki A; Kamo M
J Biochem; 2013 Mar; 153(3):303-15. PubMed ID: 23248240
[TBL] [Abstract][Full Text] [Related]
38. Autocrine motility factor promotes epithelial-mesenchymal transition in endometrial cancer via MAPK signaling pathway.
Li Y; Che Q; Bian Y; Zhou Q; Jiang F; Tong H; Ke J; Wang K; Wan XP
Int J Oncol; 2015 Sep; 47(3):1017-24. PubMed ID: 26201353
[TBL] [Abstract][Full Text] [Related]
39. A multi-cancer mesenchymal transition gene expression signature is associated with prolonged time to recurrence in glioblastoma.
Cheng WY; Kandel JJ; Yamashiro DJ; Canoll P; Anastassiou D
PLoS One; 2012; 7(4):e34705. PubMed ID: 22493711
[TBL] [Abstract][Full Text] [Related]
40. Tumor Budding, EMT and Cancer Stem Cells in T1-2/N0 Oral Squamous Cell Carcinomas.
Attramadal CG; Kumar S; Boysen ME; Dhakal HP; Nesland JM; Bryne M
Anticancer Res; 2015 Nov; 35(11):6111-20. PubMed ID: 26504037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
